|
Volumn 39 Suppl 2, Issue , 2009, Pages 27-31
|
A review of STRIDE-2 and STRIDE-2X: the case for selective endothelin receptor blockade.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
ANTIHYPERTENSIVE AGENT;
BOSENTAN;
ENDOTHELIN A RECEPTOR;
ENDOTHELIN B RECEPTOR;
ISOXAZOLE DERIVATIVE;
SITAXSENTAN;
SULFONAMIDE;
THIOPHENE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
HUMAN;
LIVER;
MALE;
METABOLISM;
MIDDLE AGED;
PULMONARY HYPERTENSION;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIHYPERTENSIVE AGENTS;
FEMALE;
HUMANS;
HYPERTENSION, PULMONARY;
ISOXAZOLES;
LIVER;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTOR, ENDOTHELIN A;
RECEPTOR, ENDOTHELIN B;
SULFONAMIDES;
SURVIVAL ANALYSIS;
THIOPHENES;
TRANSAMINASES;
TREATMENT OUTCOME;
|
EID: 68849086372
PISSN: None
EISSN: 13652362
Source Type: Journal
DOI: 10.1111/j.1365-2362.2009.02118.x Document Type: Article |
Times cited : (8)
|
References (0)
|